Benzinga
  • 2 months ago
CVS Health's board has engaged advisors for a strategic review amid potential activist pressure and a significantly depressed stock price. The review has been ongoing, but no actions are guaranteed, according to sources. CVS CEO Karen Lynch recently met with Glenview Capital to discuss plans to revive the company’s stock. Its insurance business faces challenges due to rising medical costs. CVS shares rose by more than 2% in after-hours trading following the news.

Category

🗞
News
Transcript
00:00It's Benzinga, and here's what's on the block.
00:03CVS Health's board has engaged advisors for a strategic review amid potential activist
00:08pressure and a significantly depressed stock price.
00:11The review has been ongoing, but no actions are guaranteed, according to sources.
00:16CVS CEO Karen Lynch recently met with Glenview Capital to discuss plans to revive the company's
00:21stock.
00:22Its insurance business faces challenges due to rising medical costs.
00:26CVS shares rose by more than 2 percent in after-hours trading following the news.
00:30For all things money, visit Benzinga.com.

Recommended

0:44
I
Up next
CVS Appoints David Joyner As CEO Amid Struggles With Falling Shares, Rising Costs, And Pressure From Lawmakers
Benzinga
1:30
The Health of Your Eyes Can Indicate True Biological Age, Study Shows
Wibbitz Top Stories
1:06
Why CVS Health Stock Is Tumbling Thursday
Benzinga
0:38
CVS CEO Karen Lynch Takes Charge of Aetna as Financial Goals Are Missed. Financial Shortfalls Prompt CVS Shift.
Benzinga
0:41
Walgreens Shares Surge 20% On Sycamore Partners Buyout Talks
Benzinga
9:36
Ford Upped To A "Buy" After Tesla Partnership and Nvidia Again! - $TSLA $F $NVDA
Benzinga
1:04
Nvidia Insiders Continue To Sell Shares After Hitting All-Time Highs, $1 Trillion Market Cap: What Investors Should Know - $NVDA
Benzinga
1:00
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Benzinga
2:34
Disaster Stock Of The Day: Why Dick's Sporting Goods Shares Are Diving Today $DKS
Benzinga
5:41
Earnings Highlights & A Huge Upcoming Catalyst For Viking Therapeutics, Mark This Date
Benzinga
0:43
Brian Niccol Outlines Vision To Reconnect Starbucks With Community Coffeehouse Roots On His 2nd Day As CEO
Benzinga
1:03
Jim Cramer Backs Viking's IPO Despite Premium Price: "I Think It's Going To Be A Winner"
Benzinga
13:43
Short Sellers CRASH Square $SQ Stock...But Cathie Wood is Buying!
Bullish Studio
1:51
AMC shares traded higher after the company reported better-than-expected Q2 results and a 12.2% increase in theater attendance
Benzinga
13:38
Business Tit-Bits: LIC IPO, A Hype and Hoax
HW News English
0:30
Walgreens Agrees To $100 Million Settlement Over Alleged Deceptive Pricing Of Generic Drugs
Benzinga
3:33
Spirit Airlines Shares Plummet Following A Report Suggesting That The Company Is Exploring The Potential Of Filing For Bankruptcy
Benzinga
3:34
Netflix Loses $9B In Value IN ONE DAY: Everything Investors Need To Know
Benzinga
1:30
Walgreens Plans ‘Significant’ Store Closures
Wibbitz Top Stories
0:46
Cathie Wood's Ark Sells $22M Worth Of Tesla Shares Following Blockbuster Q3 Rally
Benzinga
4:00
Will CrowdStrike Stock Bounce Back?
Benzinga
0:56
Target Introduces TruScan Tech To Combat Self-Checkout Theft: Report
Benzinga
11:58
GameStop Shares Take A Hit After 'Roaring Kitty' Discloses 6.6% Stake In Chewy And Faces A Manipulation Lawsuit: Everything You Need To Know
Benzinga
0:59
Wall Street's Most Accurate Analysts Say Hold These 3 Consumer Stocks Delivering High-Dividend Yields
Benzinga
3:12
Disaster Stock Of The Day: Humana Faces Sharp Decline In Medicare Star Ratings For 2025, Braces For 2026 Revenue Hit
Benzinga